Clinical
Trials
If you are a patient or health care provider who would like more information about a clinical trial, please contact our research team.
If you are a patient or health care provider who would like more information about a clinical trial, please contact our research team.
-
The Study of Lifirafenib in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumors
Condition:
Advanced solid tumors
Molecule:Lifirafenib
-
A Study of Zanubrutinib Versus Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Condition:
Leukemia, Lymphoma
Molecule:Zanubrutinib
-
A Phase 1b Study to Assess Sitravatinib in Combination With Tislelizumab in Patients With Advanced Solid Tumors
Condition:
Advanced solid tumors
Molecule:Sitravatinib + Tislelizumab
-
Study of BGB-A425 in Combination With Tislelizumab in Advanced Solid Tumors
Condition:
Advanced solid tumors
Molecule:BGB-425 + Tislelizumab
-
Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors
Condition:
Advanced solid tumors
Molecule:BGB-A333 + Tislelizumab
-
Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Deficiency
Condition:
Prostate Cancer
Molecule:Pamiparib
-
A Study Evaluating the Efficacy and Safety of Tislelizumab Versus Chemotherapy in Advanced Non-Squamous NSCLC
Condition:
Lung Cancer
Molecule:Tislelizumab
-
A Study of Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer
Condition:
Lung Cancer
Molecule:Tislelizumab
-
A Study of Tislelizumab Versus Chemotherapy as First Line Treatment in Patients With Advanced Esophageal Squamous Cell Carcinoma (ESCC)
Condition:
Esophageal Cancer
Molecule:Tislelizumab
-
Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma
Condition:
Gastric Cancer, Esophageal Cancer
Molecule:Tislelizumab
See All Trials
Clinical trials are an important part of our research and development efforts and help make possible access to safe and potentially life-saving treatments.